Status:

UNKNOWN

The Variation of Movement Related Cortical Potential, Cortico-cortical Inhibition, and Motor Evoked Potential in Intracerebral Implantation of Antologous Peripheral Blood Stem Cells(CD34)in Old Ischemic Stroke

Lead Sponsor:

China Medical University Hospital

Conditions:

Stroke

Eligibility:

All Genders

30+ years

Brief Summary

Stem cell theray in old stroke patients is a study to treat stroke patients approved before in our hospital. We recruit these patients who received stem cell therapy and completed the study. We adopte...

Eligibility Criteria

Inclusion

  • old cerebral infarction (middle cerebral artery territory as documented on the T2 weight image \[T2WI\] of MRI) 2.between 6 months and 5 years of onset 3.National Institute of Health stroke scale (NIHSS) of between 9 and 20.

Exclusion

  • Seizure history 2. Pacemaker insertion

Key Trial Info

Start Date :

October 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2010

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT01239602

Start Date

October 1 2010

End Date

October 1 2010

Last Update

November 11 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

China Medical University Hospital

Taichung, Taiwan, Taiwan, 404